Keywords: HER2 مثبت; Trastuzumab; Small tumours; Elderly; Early breast cancer; Adjuvant therapy; HER2-positive;
مقالات ISI HER2 مثبت (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer
Keywords: HER2 مثبت; Metastatic breast cancer; HER2-positive; Body mass index; Trastuzumab;
Expression of truncated HER2 and its prognostic value in HER2-positive breast cancer patients
Keywords: HER2 مثبت; Breast cancer; HER2-positive; Trastuzumab; p95-HER2;
When and how to treat women with HER2-positive, small (pT1a-b), node-negative breast cancer?
Keywords: HER2 مثبت; Small (pT1a-b); HER2-positive; Node-negative; Breast cancer; Chemotherapy; Trastuzumab;
Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study
Keywords: HER2 مثبت; Screening; Cancer registry; Interval cancer; HER2-positive; pT1a; Breast cancer;
Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection
Keywords: HER2 مثبت; Breast cancer epidemiology; Central nervous system metastasis; HER2-positive; Metastatic breast cancer; Prognosis;
Trastuzumab uptake in HER2-positive breast cancer patients: a systematic review and meta-analysis of observational studies
Keywords: HER2 مثبت; HER2-positive; Breast cancer; Trastuzumab; Uptake; Disparity;
More than just the median: Calculating survival times for patients with HER2 positive, metastatic breast cancer using data from recent randomised trials
Keywords: HER2 مثبت; Estimating survival times; HER2-positive; Metastatic breast cancer;
Original ResearchPIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer
Keywords: HER2 مثبت; Buparlisib; Lapatinib; Breast cancer; HER2-positive; Trastuzumab-resistant;
Original ResearchSuperimposable outcomes for sequential and concomitant administration of adjuvant trastuzumab in HER2-positive breast cancer: Results from the SIGNAL/PHARE prospective cohort
Keywords: HER2 مثبت; Trastuzumab; Adjuvant; Breast cancer; Chemotherapy; HER2-positive;
Prognostic risk factors for treatment decision in pT1a,b N0M0 HER2-positive breast cancers
Keywords: HER2 مثبت; HER2-positive; pT1a,b; Prognostic factors; Breast cancer; Interval cancer risk
Insights into biology of luminal HER2 vs. enriched HER2 subtypes: Therapeutic implications
Keywords: HER2 مثبت; Early breast cancer; Endocrine therapy; HER2-positive; Pertuzumab; T-DM1; Trastuzumab;
Optimal adjuvant treatment for patients with HER2-positive breast cancer in 2015
Keywords: HER2 مثبت; Breast cancer; HER2-positive; Adjuvant; Biomarkers;
Balancing activity and tolerability of neoadjuvant paclitaxel- and docetaxel-based chemotherapy for HER2-positive early stage breast cancer: Sensitivity analysis of randomized trials
Keywords: HER2 مثبت; Breast cancer; Paclitaxel; Docetaxel; Neoadjuvant; HER2-positive; Sensitivity analysis
Specific aptamer-conjugated mesoporous silica-carbon nanoparticles for HER2-targeted chemo-photothermal combined therapy
Keywords: HER2 مثبت; HB5 aptamer; Mesoporous silica-carbon nanoparticles; Chemo-photothermal therapy; HER2-positive; Breast cancer;
Antiangiogenic Therapy in Patients With HER2-Positive Metastatic Breast Cancer: A Case Series
Keywords: HER2 مثبت; Aflibercept; Bevacizumab; HER2-positive; Metastatic breast cancer;
Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California
Keywords: HER2 مثبت; Breast cancer subtypes; Disparities; Asian Americans; Triple-negative; HER2-positive;
Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients
Keywords: HER2 مثبت; Breast cancer; HER2-positive; HER3; Trastuzumab;
Trastuzumab Retreatment after Relapse on Adjuvant Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Final Results of the Retreatment after Herceptin Adjuvant Trial
Keywords: HER2 مثبت; HER2-positive; metastatic breast cancer; retreatment; taxane; trastuzumab;
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials
Keywords: HER2 مثبت; Meta-analysis; Breast cancer; Neoadjuvant; Trastuzumab; HER2-positive
Adjuvant chemotherapy in T1a/bN0 HER2-positive or triple-negative breast cancers: Application and outcomes
Keywords: HER2 مثبت; Stage I breast cancer; HER2-positive; Triple-negative; Adjuvant chemotherapy;
A Pooled Analysis of 2618 Patients Treated With Trastuzumab Beyond Progression for Advanced Breast Cancer
Keywords: HER2 مثبت; HER2-positive; Metastatic breast cancer; Second-line
Therapeutic approaches for HER2-positive brain metastases: Circumventing the blood–brain barrier
Keywords: HER2 مثبت; Blood–brain barrier; Trastuzumab; HER2-positive; Metastatic breast cancer; Central nervous system; Brain metastases
Clinicopathological Features Among Patients With Advanced Human Epidermal Growth Factor–2-Positive Breast Cancer With Prolonged Clinical Benefit to First-Line Trastuzumab-Based Therapy: A Retrospective Cohort Study
Keywords: HER2 مثبت; HER2-positive; Outcomes; Treatment Duration
Breast cancer and HSP90 inhibitors: Is there a role beyond the HER2-positive subtype?
Keywords: HER2 مثبت; HSP molecular chaperone; HSP90 inhibitors; Breast cancer; HER2-positive; Hormonal receptor positive; Triple negative
First-line endocrine therapy alone could be a reasonable treatment option for hormone-positive, HER2-positive metastatic breast cancer
Keywords: HER2 مثبت; metastatic breast cancer; ER-positive; HER2-positive; endocrine therapy; trastuzumab;
Case histories: breast cancer
Keywords: HER2 مثبت; Anthracycline; Breast cancer; Elderly patients; HER2-positive; Liposomal doxorubicin; Trastuzumab; Triple-negative;
Brain metastases in HER2-positive breast cancer: The evolving role of lapatinib
Keywords: HER2 مثبت; Brain metastases; Breast cancer; HER2-positive; Trastuzumab; Lapatinib
Facilitating consensus by examining patterns of treatment effects
Keywords: HER2 مثبت; Breast cancer; Adjuvant therapies; Clinical trials; Endocrine responsive; HER2-positive; Patterns of treatment effect